Three days after Hong Kong paused distribution of BioNTech ’s Covid-19 vaccine over concerns about defective vials, an early investigation found “no evidence indicating any safety risks,” the local …
( read original story …)
The HongKong News
Three days after Hong Kong paused distribution of BioNTech ’s Covid-19 vaccine over concerns about defective vials, an early investigation found “no evidence indicating any safety risks,” the local …
( read original story …)